Vax market authorisation conditional on data submission: Health Ministry

The market authorisation of two Covid vaccines - Covaxin and Covishield, given by drug regulator Drug Controller General of India is the subject to the condition of submission of ongoing clinical trial data and safety data of the vaccines, the ...

Related Keywords

India ,New Delhi ,Delhi , ,Union Health Ministry ,Drug Controller General ,Adverse Event Following Immunisation ,Adverse Event ,Special Interest ,Central Drugs Standard Control Organiation ,Subject Expert Committee ,Market Authorisation ,